Types of Biological Cancer Immunotherapy

THE FIELD OF IMMUNOTHERAPY IS COMPRISED OF:

  • Alternative Medicines - Chinese herbs, dietary supplements and homeopathic medicines. These are often used as supplements to traditional medicine or when traditional medicine has failed.

  • Biologicals - Pharmaceutical grade products developed by biotechnology/drug companies that are clinically tested and require government approval/clearance for marketing.

Within the field of biologicals there are three main categories of immunotherapy; passive, active and a new class called combination immunotherapy.

Passive immunotherapies do not rely on the body to attack the disease; passive immunotherapies employ immune system components (such as antibodies) created outside of the body to destroy the cancer cells.

Active immunotherapies stimulate the body's own immune system to fight the tumor.

Combination immunotherapy, a new class of immunotherapy drugs, possess both active and passive activity.

Within these categories are the following types of immunotherapies:
       
  o Passive Immunotherapy  
   
       
  Monoclonal Antibodies (mAbs)  
   
     
> Limitations of mAbs  
     
 
 
  o Active Immunotherapy  
   
       
  Cancer Vaccines  
   
     
> Limitations of Cancer Vaccines  
     
 
  Cellular Therapies  
   
     
> Limitations of Cellular Therapies as Cancer Immunotherapies  
     
 
  Adjuvants  
   
     
> Limitations of Adjuvant Immunotherapies  
     
 
 
  o Investigational Combination Immunotherapy  
   
       
  Multikine (Leukocyte Interleukin, Injection)*  
       
 

 

* Multikine is the trademark that CEL-SCI has registered for this investigational therapy, and this proprietary name is subject to FDA review in connection with our future anticipated regulatory submission for approval. Multikine has not been licensed or approved by the FDA or any other regulatory agency. Neither has its safety or efficacy been established for any use. Lastly, no definitive conclusions can be drawn from these early-phase, clinical-trials data involving the investigational therapy Multikine (Leukocyte Interleukin, Injection). Further research is required, and early-phase clinical trial results must be confirmed in the well-controlled, Phase III clinical trial of this investigational therapy that is currently in progress.